#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1.
1-1	0-2	1.	_	_	_	_

#Text=Introduction
2-1	3-15	Introduction	abstract	new	_	_

#Text=Owing to the developments in biological fields , personalized diagnoses and treatments at the single cell level have become important , which will introduce new potential breakthroughs for biomedicine .
3-1	16-21	Owing	_	_	_	_
3-2	22-24	to	_	_	_	_
3-3	25-28	the	abstract[2]	new[2]	_	_
3-4	29-41	developments	abstract[2]	new[2]	_	_
3-5	42-44	in	abstract[2]	new[2]	_	_
3-6	45-55	biological	abstract[2]|abstract[3]	new[2]|new[3]	coref	13-7[97_3]
3-7	56-62	fields	abstract[2]|abstract[3]	new[2]|new[3]	_	_
3-8	63-64	,	_	_	_	_
3-9	65-77	personalized	abstract[4]	new[4]	_	_
3-10	78-87	diagnoses	abstract[4]	new[4]	_	_
3-11	88-91	and	_	_	_	_
3-12	92-102	treatments	abstract[5]	new[5]	_	_
3-13	103-105	at	abstract[5]	new[5]	_	_
3-14	106-109	the	abstract[5]|abstract[7]	new[5]|new[7]	coref	5-17[24_7]
3-15	110-116	single	abstract[5]|abstract[7]	new[5]|new[7]	_	_
3-16	117-121	cell	abstract[5]|place|abstract[7]	new[5]|new|new[7]	coref	5-8
3-17	122-127	level	abstract[5]|abstract[7]	new[5]|new[7]	_	_
3-18	128-132	have	_	_	_	_
3-19	133-139	become	_	_	_	_
3-20	140-149	important	_	_	_	_
3-21	150-151	,	_	_	_	_
3-22	152-157	which	_	_	_	_
3-23	158-162	will	_	_	_	_
3-24	163-172	introduce	_	_	_	_
3-25	173-176	new	abstract[8]	new[8]	_	_
3-26	177-186	potential	abstract[8]	new[8]	_	_
3-27	187-200	breakthroughs	abstract[8]	new[8]	_	_
3-28	201-204	for	abstract[8]	new[8]	_	_
3-29	205-216	biomedicine	abstract[8]|abstract	new[8]|new	_	_
3-30	217-218	.	_	_	_	_

#Text=Recently , the early detection of cancer and drug action on cancer have attracted considerable attention in the field of biotechnology .
4-1	219-227	Recently	_	_	_	_
4-2	228-229	,	_	_	_	_
4-3	230-233	the	event[10]	new[10]	_	_
4-4	234-239	early	event[10]	new[10]	_	_
4-5	240-249	detection	event[10]	new[10]	_	_
4-6	250-252	of	event[10]	new[10]	_	_
4-7	253-259	cancer	event[10]|abstract	new[10]|new	coref	4-12
4-8	260-263	and	_	_	_	_
4-9	264-268	drug	substance|abstract[13]	new|new[13]	coref	8-21
4-10	269-275	action	abstract[13]	new[13]	_	_
4-11	276-278	on	abstract[13]	new[13]	_	_
4-12	279-285	cancer	abstract[13]|abstract	new[13]|giv	coref	6-9
4-13	286-290	have	_	_	_	_
4-14	291-300	attracted	_	_	_	_
4-15	301-313	considerable	abstract[15]	new[15]	coref	14-7[0_15]
4-16	314-323	attention	abstract[15]	new[15]	_	_
4-17	324-326	in	abstract[15]	new[15]	_	_
4-18	327-330	the	abstract[15]|abstract[16]	new[15]|new[16]	_	_
4-19	331-336	field	abstract[15]|abstract[16]	new[15]|new[16]	_	_
4-20	337-339	of	abstract[15]|abstract[16]	new[15]|new[16]	_	_
4-21	340-353	biotechnology	abstract[15]|abstract[16]|abstract	new[15]|new[16]|new	_	_
4-22	354-355	.	_	_	_	_

#Text=Microfluidic device is a useful tool in cell research with advantages such as high-throughput manipulation , high level of integration , and requirement of less time and fewer reagents .
5-1	356-368	Microfluidic	object[18]	new[18]	coref	5-4[19_18]
5-2	369-375	device	object[18]	new[18]	_	_
5-3	376-378	is	_	_	_	_
5-4	379-380	a	object[19]	giv[19]	coref	7-4[36_19]
5-5	381-387	useful	object[19]	giv[19]	_	_
5-6	388-392	tool	object[19]	giv[19]	_	_
5-7	393-395	in	object[19]	giv[19]	_	_
5-8	396-400	cell	object[19]|place|abstract[21]	giv[19]|giv|new[21]	coref|coref	6-10|13-20[105_21]
5-9	401-409	research	object[19]|abstract[21]	giv[19]|new[21]	_	_
5-10	410-414	with	object[19]	giv[19]	_	_
5-11	415-425	advantages	object[19]|abstract[22]	giv[19]|new[22]	coref	16-4[122_22]
5-12	426-430	such	object[19]|abstract[22]	giv[19]|new[22]	_	_
5-13	431-433	as	object[19]|abstract[22]	giv[19]|new[22]	_	_
5-14	434-449	high-throughput	object[19]|abstract[22]|abstract[23]	giv[19]|new[22]|new[23]	_	_
5-15	450-462	manipulation	object[19]|abstract[22]|abstract[23]	giv[19]|new[22]|new[23]	_	_
5-16	463-464	,	object[19]|abstract[22]	giv[19]|new[22]	_	_
5-17	465-469	high	object[19]|abstract[22]|abstract[24]	giv[19]|new[22]|giv[24]	_	_
5-18	470-475	level	object[19]|abstract[22]|abstract[24]	giv[19]|new[22]|giv[24]	_	_
5-19	476-478	of	object[19]|abstract[22]|abstract[24]	giv[19]|new[22]|giv[24]	_	_
5-20	479-490	integration	object[19]|abstract[22]|abstract[24]|abstract	giv[19]|new[22]|giv[24]|new	_	_
5-21	491-492	,	object[19]|abstract[22]	giv[19]|new[22]	_	_
5-22	493-496	and	object[19]|abstract[22]	giv[19]|new[22]	_	_
5-23	497-508	requirement	object[19]|abstract[22]|abstract[26]	giv[19]|new[22]|new[26]	_	_
5-24	509-511	of	object[19]|abstract[22]|abstract[26]	giv[19]|new[22]|new[26]	_	_
5-25	512-516	less	object[19]|abstract[22]|abstract[26]|abstract[27]	giv[19]|new[22]|new[26]|new[27]	_	_
5-26	517-521	time	object[19]|abstract[22]|abstract[26]|abstract[27]	giv[19]|new[22]|new[26]|new[27]	_	_
5-27	522-525	and	object[19]|abstract[22]|abstract[26]	giv[19]|new[22]|new[26]	_	_
5-28	526-531	fewer	object[19]|abstract[22]|abstract[26]|abstract[28]	giv[19]|new[22]|new[26]|new[28]	_	_
5-29	532-540	reagents	object[19]|abstract[22]|abstract[26]|abstract[28]	giv[19]|new[22]|new[26]|new[28]	_	_
5-30	541-542	.	_	_	_	_

#Text=Furthermore , microfluidic devices have broad applications in cancer cell trapping .
6-1	543-554	Furthermore	_	_	_	_
6-2	555-556	,	_	_	_	_
6-3	557-569	microfluidic	object[29]	new[29]	coref	15-7[116_29]
6-4	570-577	devices	object[29]	new[29]	_	_
6-5	578-582	have	_	_	_	_
6-6	583-588	broad	abstract[30]	new[30]	_	_
6-7	589-601	applications	abstract[30]	new[30]	_	_
6-8	602-604	in	abstract[30]	new[30]	_	_
6-9	605-611	cancer	abstract[30]|abstract|abstract[33]	new[30]|giv|new[33]	coref	22-24[165_33]
6-10	612-616	cell	abstract[30]|place|abstract[33]	new[30]|giv|new[33]	coref	7-14
6-11	617-625	trapping	abstract[30]|abstract[33]	new[30]|new[33]	_	_
6-12	626-627	.	_	_	_	_

#Text=Microwell arrays in microfluidic device are often used to trap cells and construct cell arrays .
7-1	628-637	Microwell	event|object[35]	new|new[35]	coref|coref	7-14[39_35]|8-33
7-2	638-644	arrays	object[35]	new[35]	_	_
7-3	645-647	in	object[35]	new[35]	_	_
7-4	648-660	microfluidic	object[35]|object[36]	new[35]|giv[36]	coref	8-4[42_36]
7-5	661-667	device	object[35]|object[36]	new[35]|giv[36]	_	_
7-6	668-671	are	_	_	_	_
7-7	672-677	often	_	_	_	_
7-8	678-682	used	_	_	_	_
7-9	683-685	to	_	_	_	_
7-10	686-690	trap	_	_	_	_
7-11	691-696	cells	object	new	coref	8-1
7-12	697-700	and	_	_	_	_
7-13	701-710	construct	_	_	_	_
7-14	711-715	cell	place|object[39]	giv|giv[39]	coref|coref	8-42|9-20[61_39]
7-15	716-722	arrays	object[39]	giv[39]	_	_
7-16	723-724	.	_	_	_	_

#Text=Cells trapped in a microfluidic device can be cultured , used to detect markers , manipulated , and employed for drug screening . Rettig et al. have developed an easy-to-use method using microwell array fabricated through soft lithography for a single cell trap .
8-1	725-730	Cells	object	giv	_	_
8-2	731-738	trapped	_	_	_	_
8-3	739-741	in	_	_	_	_
8-4	742-743	a	object[42]	giv[42]	coref	10-12[75_42]
8-5	744-756	microfluidic	person|object[42]	new|giv[42]	coref	14-19
8-6	757-763	device	object[42]	giv[42]	_	_
8-7	764-767	can	_	_	_	_
8-8	768-770	be	_	_	_	_
8-9	771-779	cultured	_	_	_	_
8-10	780-781	,	_	_	_	_
8-11	782-786	used	_	_	_	_
8-12	787-789	to	_	_	_	_
8-13	790-796	detect	_	_	_	_
8-14	797-804	markers	abstract	new	_	_
8-15	805-806	,	_	_	_	_
8-16	807-818	manipulated	_	_	_	_
8-17	819-820	,	_	_	_	_
8-18	821-824	and	_	_	_	_
8-19	825-833	employed	_	_	_	_
8-20	834-837	for	_	_	_	_
8-21	838-842	drug	substance|event[45]	giv|new[45]	_	_
8-22	843-852	screening	event[45]	new[45]	_	_
8-23	853-854	.	_	_	_	_
8-24	855-861	Rettig	person	new	_	_
8-25	862-864	et	_	_	_	_
8-26	865-868	al.	_	_	_	_
8-27	869-873	have	_	_	_	_
8-28	874-883	developed	_	_	_	_
8-29	884-886	an	abstract[47]	new[47]	_	_
8-30	887-898	easy-to-use	abstract[47]	new[47]	_	_
8-31	899-905	method	abstract[47]	new[47]	_	_
8-32	906-911	using	_	_	_	_
8-33	912-921	microwell	place|place[49]	giv|new[49]	coref|coref	9-20|9-49[0_49]
8-34	922-927	array	place[49]	new[49]	_	_
8-35	928-938	fabricated	_	_	_	_
8-36	939-946	through	_	_	_	_
8-37	947-951	soft	object[50]	new[50]	coref	15-11[117_50]
8-38	952-963	lithography	object[50]	new[50]	_	_
8-39	964-967	for	_	_	_	_
8-40	968-969	a	object[52]	new[52]	_	_
8-41	970-976	single	object[52]	new[52]	_	_
8-42	977-981	cell	place|object[52]	giv|new[52]	coref	9-1[53_0]
8-43	982-986	trap	object[52]	new[52]	_	_
8-44	987-988	.	_	_	_	_

#Text=Anchorage-dependent cell ( 3T3 fibroblast cells ) and anchorage-independent cell ( Basophilic leukemia cell ) were successfully trapped in microwell arrays . Lin et al. improved the traditional structure of microwells and introduced a double-well design , including a tapping well and a culturing well for single cell array construction .
9-1	989-1008	Anchorage-dependent	place[53]	giv[53]	appos	9-4[55_53]
9-2	1009-1013	cell	place[53]	giv[53]	_	_
9-3	1014-1015	(	_	_	_	_
9-4	1016-1019	3T3	place[55]	giv[55]	coref	9-9[57_55]
9-5	1020-1030	fibroblast	event|place[55]	new|giv[55]	_	_
9-6	1031-1036	cells	place[55]	giv[55]	_	_
9-7	1037-1038	)	_	_	_	_
9-8	1039-1042	and	_	_	_	_
9-9	1043-1064	anchorage-independent	person|place[57]	new|giv[57]	appos	9-12[59_57]
9-10	1065-1069	cell	place[57]	giv[57]	_	_
9-11	1070-1071	(	_	_	_	_
9-12	1072-1082	Basophilic	place[59]	giv[59]	coref	9-48[0_59]
9-13	1083-1091	leukemia	abstract|place[59]	new|giv[59]	_	_
9-14	1092-1096	cell	place[59]	giv[59]	_	_
9-15	1097-1098	)	_	_	_	_
9-16	1099-1103	were	_	_	_	_
9-17	1104-1116	successfully	_	_	_	_
9-18	1117-1124	trapped	_	_	_	_
9-19	1125-1127	in	_	_	_	_
9-20	1128-1137	microwell	event|object[61]	giv|giv[61]	coref|coref	11-5|14-23[114_61]
9-21	1138-1144	arrays	object[61]	giv[61]	_	_
9-22	1145-1146	.	_	_	_	_
9-23	1147-1150	Lin	person	new	_	_
9-24	1151-1153	et	_	_	_	_
9-25	1154-1157	al.	_	_	_	_
9-26	1158-1166	improved	_	_	_	_
9-27	1167-1170	the	abstract[63]	new[63]	_	_
9-28	1171-1182	traditional	abstract[63]	new[63]	_	_
9-29	1183-1192	structure	abstract[63]	new[63]	_	_
9-30	1193-1195	of	abstract[63]	new[63]	_	_
9-31	1196-1206	microwells	abstract[63]|object	new[63]|new	coref	12-16[94_0]
9-32	1207-1210	and	_	_	_	_
9-33	1211-1221	introduced	_	_	_	_
9-34	1222-1223	a	abstract[65]	new[65]	_	_
9-35	1224-1235	double-well	abstract[65]	new[65]	_	_
9-36	1236-1242	design	abstract[65]	new[65]	_	_
9-37	1243-1244	,	abstract[65]	new[65]	_	_
9-38	1245-1254	including	abstract[65]	new[65]	_	_
9-39	1255-1256	a	abstract[65]	new[65]	_	_
9-40	1257-1264	tapping	abstract[65]	new[65]	_	_
9-41	1265-1269	well	abstract[65]	new[65]	_	_
9-42	1270-1273	and	abstract[65]	new[65]	_	_
9-43	1274-1275	a	abstract[65]|abstract[66]	new[65]|new[66]	_	_
9-44	1276-1285	culturing	abstract[65]|abstract[66]	new[65]|new[66]	_	_
9-45	1286-1290	well	abstract[65]|abstract[66]	new[65]|new[66]	_	_
9-46	1291-1294	for	abstract[65]|abstract[66]	new[65]|new[66]	_	_
9-47	1295-1301	single	abstract[65]|abstract[66]|abstract[69]	new[65]|new[66]|new[69]	_	_
9-48	1302-1306	cell	abstract[65]|abstract[66]|place|abstract[69]	new[65]|new[66]|giv|new[69]	coref	10-3
9-49	1307-1312	array	abstract[65]|abstract[66]|place|abstract[69]	new[65]|new[66]|giv|new[69]	coref	11-3[78_0]
9-50	1313-1325	construction	abstract[65]|abstract[66]|abstract[69]	new[65]|new[66]|new[69]	_	_
9-51	1326-1327	.	_	_	_	_

#Text=Neural stem cell differentiation and A549 cell proliferation were performed using this device .
10-1	1328-1334	Neural	event[72]	new[72]	_	_
10-2	1335-1339	stem	plant|event[72]	new|new[72]	_	_
10-3	1340-1344	cell	place|event[72]	giv|new[72]	coref	10-7
10-4	1345-1360	differentiation	event[72]	new[72]	_	_
10-5	1361-1364	and	_	_	_	_
10-6	1365-1369	A549	event[74]	new[74]	coref	13-13[101_74]
10-7	1370-1374	cell	place|event[74]	giv|new[74]	coref	12-1[90_0]
10-8	1375-1388	proliferation	event[74]	new[74]	_	_
10-9	1389-1393	were	_	_	_	_
10-10	1394-1403	performed	_	_	_	_
10-11	1404-1409	using	_	_	_	_
10-12	1410-1414	this	object[75]	giv[75]	coref	13-1[96_75]
10-13	1415-1421	device	object[75]	giv[75]	_	_
10-14	1422-1423	.	_	_	_	_

#Text=Assal constructed a 3D microwell array using polyethylene glycol ( PEG ) solution cured by ultraviolet ( UV ) light based on a polydimethylsiloxane ( PDMS ) mold .
11-1	1424-1429	Assal	person	new	_	_
11-2	1430-1441	constructed	_	_	_	_
11-3	1442-1443	a	place[78]	giv[78]	_	_
11-4	1444-1446	3D	place[78]	giv[78]	_	_
11-5	1447-1456	microwell	object|place[78]	giv|giv[78]	coref	14-23
11-6	1457-1462	array	place[78]	giv[78]	_	_
11-7	1463-1468	using	_	_	_	_
11-8	1469-1481	polyethylene	substance|object[80]	new|new[80]	appos	11-11[0_80]
11-9	1482-1488	glycol	object[80]	new[80]	_	_
11-10	1489-1490	(	_	_	_	_
11-11	1491-1494	PEG	object	giv	coref	24-1[172_0]
11-12	1495-1496	)	_	_	_	_
11-13	1497-1505	solution	substance	new	_	_
11-14	1506-1511	cured	_	_	_	_
11-15	1512-1514	by	_	_	_	_
11-16	1515-1526	ultraviolet	abstract	new	appos	11-18
11-17	1527-1528	(	_	_	_	_
11-18	1529-1531	UV	abstract	giv	_	_
11-19	1532-1533	)	_	_	_	_
11-20	1534-1539	light	abstract	new	_	_
11-21	1540-1545	based	_	_	_	_
11-22	1546-1548	on	_	_	_	_
11-23	1549-1550	a	object[86]|object[88]	new[86]|new[88]	appos|coref	11-26[0_86]|18-10[136_88]
11-24	1551-1571	polydimethylsiloxane	object[86]|object[88]	new[86]|new[88]	_	_
11-25	1572-1573	(	object[88]	new[88]	_	_
11-26	1574-1578	PDMS	object|object[88]	giv|new[88]	_	_
11-27	1579-1580	)	object[88]	new[88]	_	_
11-28	1581-1585	mold	object[88]	new[88]	_	_
11-29	1586-1587	.	_	_	_	_

#Text=Human B cells infected by Kaposi ’s sarcoma-associated herpesvirus ( KSHV ) were trapped in these microwells for 3D culture .
12-1	1588-1593	Human	place[90]	giv[90]	coref	13-10[0_90]
12-2	1594-1595	B	person|place[90]	new|giv[90]	_	_
12-3	1596-1601	cells	place[90]	giv[90]	_	_
12-4	1602-1610	infected	_	_	_	_
12-5	1611-1613	by	_	_	_	_
12-6	1614-1620	Kaposi	person[91]|object[92]	new[91]|new[92]	appos	12-11[0_92]
12-7	1621-1623	’s	person[91]|object[92]	new[91]|new[92]	_	_
12-8	1624-1642	sarcoma-associated	object[92]	new[92]	_	_
12-9	1643-1654	herpesvirus	object[92]	new[92]	_	_
12-10	1655-1656	(	_	_	_	_
12-11	1657-1661	KSHV	object	giv	_	_
12-12	1662-1663	)	_	_	_	_
12-13	1664-1668	were	_	_	_	_
12-14	1669-1676	trapped	_	_	_	_
12-15	1677-1679	in	_	_	_	_
12-16	1680-1685	these	object[94]	giv[94]	_	_
12-17	1686-1696	microwells	object[94]	giv[94]	_	_
12-18	1697-1700	for	object[94]	giv[94]	_	_
12-19	1701-1703	3D	object[94]|abstract[95]	giv[94]|new[95]	_	_
12-20	1704-1711	culture	object[94]|abstract[95]	giv[94]|new[95]	_	_
12-21	1712-1713	.	_	_	_	_

#Text=Microfluidic device has been applied in various fields for cell separation , cell proliferation , and cell behavior in biology research .
13-1	1714-1726	Microfluidic	object[96]	giv[96]	ana	14-4[0_96]
13-2	1727-1733	device	object[96]	giv[96]	_	_
13-3	1734-1737	has	_	_	_	_
13-4	1738-1742	been	_	_	_	_
13-5	1743-1750	applied	_	_	_	_
13-6	1751-1753	in	_	_	_	_
13-7	1754-1761	various	abstract[97]	giv[97]	_	_
13-8	1762-1768	fields	abstract[97]	giv[97]	_	_
13-9	1769-1772	for	abstract[97]	giv[97]	_	_
13-10	1773-1777	cell	abstract[97]|place|event[99]	giv[97]|giv|new[99]	coref|coref	13-13|22-21[163_99]
13-11	1778-1788	separation	abstract[97]|event[99]	giv[97]|new[99]	_	_
13-12	1789-1790	,	abstract[97]	giv[97]	_	_
13-13	1791-1795	cell	abstract[97]|place|event[101]	giv[97]|giv|giv[101]	coref	13-17
13-14	1796-1809	proliferation	abstract[97]|event[101]	giv[97]|giv[101]	_	_
13-15	1810-1811	,	abstract[97]	giv[97]	_	_
13-16	1812-1815	and	abstract[97]	giv[97]	_	_
13-17	1816-1820	cell	abstract[97]|place|abstract[103]	giv[97]|giv|new[103]	coref	14-14
13-18	1821-1829	behavior	abstract[97]|abstract[103]	giv[97]|new[103]	_	_
13-19	1830-1832	in	abstract[97]|abstract[103]	giv[97]|new[103]	_	_
13-20	1833-1840	biology	abstract[97]|abstract[103]|abstract|abstract[105]	giv[97]|new[103]|new|giv[105]	_	_
13-21	1841-1849	research	abstract[97]|abstract[103]|abstract[105]	giv[97]|new[103]|giv[105]	_	_
13-22	1850-1851	.	_	_	_	_

#Text=In particular , it has received attention for the in situ characterization of cells after trapping them using microfluidic device equipped with microwell arrays .
14-1	1852-1854	In	_	_	_	_
14-2	1855-1865	particular	_	_	_	_
14-3	1866-1867	,	_	_	_	_
14-4	1868-1870	it	object	giv	coref	14-19[112_0]
14-5	1871-1874	has	_	_	_	_
14-6	1875-1883	received	_	_	_	_
14-7	1884-1893	attention	abstract	giv	_	_
14-8	1894-1897	for	_	_	_	_
14-9	1898-1901	the	abstract[108]	new[108]	_	_
14-10	1902-1904	in	abstract[108]	new[108]	_	_
14-11	1905-1909	situ	abstract[108]	new[108]	_	_
14-12	1910-1926	characterization	abstract[108]	new[108]	_	_
14-13	1927-1929	of	abstract[108]	new[108]	_	_
14-14	1930-1935	cells	abstract[108]|place	new[108]|giv	ana	14-17
14-15	1936-1941	after	_	_	_	_
14-16	1942-1950	trapping	_	_	_	_
14-17	1951-1955	them	place	giv	coref	22-21
14-18	1956-1961	using	_	_	_	_
14-19	1962-1974	microfluidic	person|object[112]	giv|giv[112]	coref|coref	17-10|17-11[0_112]
14-20	1975-1981	device	object[112]	giv[112]	_	_
14-21	1982-1990	equipped	_	_	_	_
14-22	1991-1995	with	_	_	_	_
14-23	1996-2005	microwell	object|object[114]	giv|giv[114]	coref|coref	27-3|27-3[188_114]
14-24	2006-2012	arrays	object[114]	giv[114]	_	_
14-25	2013-2014	.	_	_	_	_

#Text=There are traditional methods for fabricating microfluidic devices such as soft lithography , photolithography , and laser direct writing .
15-1	2015-2020	There	_	_	_	_
15-2	2021-2024	are	_	_	_	_
15-3	2025-2036	traditional	abstract[115]	new[115]	coref	21-13[153_115]
15-4	2037-2044	methods	abstract[115]	new[115]	_	_
15-5	2045-2048	for	_	_	_	_
15-6	2049-2060	fabricating	_	_	_	_
15-7	2061-2073	microfluidic	object[116]	giv[116]	coref	21-18[155_116]
15-8	2074-2081	devices	object[116]	giv[116]	_	_
15-9	2082-2086	such	object[116]	giv[116]	_	_
15-10	2087-2089	as	object[116]	giv[116]	_	_
15-11	2090-2094	soft	object[116]|object[117]	giv[116]|giv[117]	coref	17-1[129_117]
15-12	2095-2106	lithography	object[116]|object[117]	giv[116]|giv[117]	_	_
15-13	2107-2108	,	object[116]	giv[116]	_	_
15-14	2109-2125	photolithography	object[116]|object	giv[116]|new	coref	16-2
15-15	2126-2127	,	object[116]	giv[116]	_	_
15-16	2128-2131	and	object[116]	giv[116]	_	_
15-17	2132-2137	laser	object[116]|person|abstract[120]	giv[116]|new|new[120]	coref|coref	19-1|19-1[140_120]
15-18	2138-2144	direct	object[116]|abstract[120]	giv[116]|new[120]	_	_
15-19	2145-2152	writing	object[116]|abstract[120]	giv[116]|new[120]	_	_
15-20	2153-2154	.	_	_	_	_

#Text=Although photolithography has the advantages of high resolution , a physical mask is essential during the fabrication process , and this technique requires extreme environmental conditions .
16-1	2155-2163	Although	_	_	_	_
16-2	2164-2180	photolithography	object	giv	_	_
16-3	2181-2184	has	_	_	_	_
16-4	2185-2188	the	abstract[122]	giv[122]	_	_
16-5	2189-2199	advantages	abstract[122]	giv[122]	_	_
16-6	2200-2202	of	abstract[122]	giv[122]	_	_
16-7	2203-2207	high	abstract[122]|abstract[123]	giv[122]|new[123]	_	_
16-8	2208-2218	resolution	abstract[122]|abstract[123]	giv[122]|new[123]	_	_
16-9	2219-2220	,	_	_	_	_
16-10	2221-2222	a	object[124]	new[124]	_	_
16-11	2223-2231	physical	object[124]	new[124]	_	_
16-12	2232-2236	mask	object[124]	new[124]	_	_
16-13	2237-2239	is	_	_	_	_
16-14	2240-2249	essential	_	_	_	_
16-15	2250-2256	during	_	_	_	_
16-16	2257-2260	the	event[126]	new[126]	_	_
16-17	2261-2272	fabrication	abstract|event[126]	new|new[126]	coref	17-10[132_0]
16-18	2273-2280	process	event[126]	new[126]	_	_
16-19	2281-2282	,	_	_	_	_
16-20	2283-2286	and	_	_	_	_
16-21	2287-2291	this	abstract[127]	new[127]	coref	22-8[158_127]
16-22	2292-2301	technique	abstract[127]	new[127]	_	_
16-23	2302-2310	requires	_	_	_	_
16-24	2311-2318	extreme	abstract[128]	new[128]	_	_
16-25	2319-2332	environmental	abstract[128]	new[128]	_	_
16-26	2333-2343	conditions	abstract[128]	new[128]	_	_
16-27	2344-2345	.	_	_	_	_

#Text=Soft lithography has been successfully and widely applied to microfluidic device fabrication .
17-1	2346-2350	Soft	abstract[129]	giv[129]	coref	23-7[168_129]
17-2	2351-2362	lithography	abstract[129]	giv[129]	_	_
17-3	2363-2366	has	_	_	_	_
17-4	2367-2371	been	_	_	_	_
17-5	2372-2384	successfully	_	_	_	_
17-6	2385-2388	and	_	_	_	_
17-7	2389-2395	widely	_	_	_	_
17-8	2396-2403	applied	_	_	_	_
17-9	2404-2406	to	_	_	_	_
17-10	2407-2419	microfluidic	person|abstract[132]	giv|giv[132]	ana|coref	18-2[0_132]|21-18
17-11	2420-2426	device	object|abstract[132]	giv|giv[132]	coref	25-17[183_0]
17-12	2427-2438	fabrication	abstract[132]	giv[132]	_	_
17-13	2439-2440	.	_	_	_	_

#Text=While it is an easy-to-use approach , it requires a pre-designed mold or stamp , making it considerably time-consuming .
18-1	2441-2446	While	_	_	_	_
18-2	2447-2449	it	abstract	giv	coref	18-4[134_0]
18-3	2450-2452	is	_	_	_	_
18-4	2453-2455	an	abstract[134]	giv[134]	ana	18-8[0_134]
18-5	2456-2467	easy-to-use	abstract[134]	giv[134]	_	_
18-6	2468-2476	approach	abstract[134]	giv[134]	_	_
18-7	2477-2478	,	_	_	_	_
18-8	2479-2481	it	abstract	giv	ana	18-17
18-9	2482-2490	requires	_	_	_	_
18-10	2491-2492	a	object[136]	giv[136]	_	_
18-11	2493-2505	pre-designed	object[136]	giv[136]	_	_
18-12	2506-2510	mold	object[136]	giv[136]	_	_
18-13	2511-2513	or	_	_	_	_
18-14	2514-2519	stamp	object	new	_	_
18-15	2520-2521	,	_	_	_	_
18-16	2522-2528	making	_	_	_	_
18-17	2529-2531	it	abstract	giv	coref	23-11[169_0]
18-18	2532-2544	considerably	_	_	_	_
18-19	2545-2559	time-consuming	_	_	_	_
18-20	2560-2561	.	_	_	_	_

#Text=Laser direct writing can fabricate complicated 3D microstructures without the need of photomasks owing to its high-resolution and flexibility .
19-1	2562-2567	Laser	person|object[140]	giv|giv[140]	_	_
19-2	2568-2574	direct	object[140]	giv[140]	_	_
19-3	2575-2582	writing	object[140]	giv[140]	_	_
19-4	2583-2586	can	_	_	_	_
19-5	2587-2596	fabricate	_	_	_	_
19-6	2597-2608	complicated	object[142]	new[142]	coref	24-14[0_142]
19-7	2609-2611	3D	abstract|object[142]	new|new[142]	_	_
19-8	2612-2627	microstructures	object[142]	new[142]	_	_
19-9	2628-2635	without	object[142]	new[142]	_	_
19-10	2636-2639	the	object[142]|abstract[143]	new[142]|new[143]	ana	19-16[0_143]
19-11	2640-2644	need	object[142]|abstract[143]	new[142]|new[143]	_	_
19-12	2645-2647	of	object[142]|abstract[143]	new[142]|new[143]	_	_
19-13	2648-2658	photomasks	object[142]|abstract[143]|object	new[142]|new[143]|new	_	_
19-14	2659-2664	owing	_	_	_	_
19-15	2665-2667	to	_	_	_	_
19-16	2668-2671	its	abstract|abstract[146]	giv|new[146]	_	_
19-17	2672-2687	high-resolution	abstract[146]	new[146]	_	_
19-18	2688-2691	and	_	_	_	_
19-19	2692-2703	flexibility	abstract	new	_	_
19-20	2704-2705	.	_	_	_	_

#Text=However , the linear scanning mode is time-consuming .
20-1	2706-2713	However	_	_	_	_
20-2	2714-2715	,	_	_	_	_
20-3	2716-2719	the	abstract[149]	new[149]	_	_
20-4	2720-2726	linear	abstract[149]	new[149]	_	_
20-5	2727-2735	scanning	abstract|abstract[149]	new|new[149]	_	_
20-6	2736-2740	mode	abstract[149]	new[149]	_	_
20-7	2741-2743	is	_	_	_	_
20-8	2744-2758	time-consuming	_	_	_	_
20-9	2759-2760	.	_	_	_	_

#Text=Therefore , tedious procedures and high-cost equipment are the main challenges of the current methods for fabricating microfluidic devices .
21-1	2761-2770	Therefore	_	_	_	_
21-2	2771-2772	,	_	_	_	_
21-3	2773-2780	tedious	abstract[150]	new[150]	_	_
21-4	2781-2791	procedures	abstract[150]	new[150]	_	_
21-5	2792-2795	and	_	_	_	_
21-6	2796-2805	high-cost	abstract[151]	new[151]	coref	21-9[152_151]
21-7	2806-2815	equipment	abstract[151]	new[151]	_	_
21-8	2816-2819	are	_	_	_	_
21-9	2820-2823	the	abstract[152]	giv[152]	_	_
21-10	2824-2828	main	abstract[152]	giv[152]	_	_
21-11	2829-2839	challenges	abstract[152]	giv[152]	_	_
21-12	2840-2842	of	abstract[152]	giv[152]	_	_
21-13	2843-2846	the	abstract[152]|abstract[153]	giv[152]|giv[153]	coref	26-3[185_153]
21-14	2847-2854	current	abstract[152]|abstract[153]	giv[152]|giv[153]	_	_
21-15	2855-2862	methods	abstract[152]|abstract[153]	giv[152]|giv[153]	_	_
21-16	2863-2866	for	_	_	_	_
21-17	2867-2878	fabricating	_	_	_	_
21-18	2879-2891	microfluidic	person|object[155]	giv|giv[155]	coref|coref	22-13|22-13[160_155]
21-19	2892-2899	devices	object[155]	giv[155]	_	_
21-20	2900-2901	.	_	_	_	_

#Text=Thus , it is crucial to develop a facile technique for creating microfluidic devices that can satisfy the requirements of cell separation and cell trapping .
22-1	2902-2906	Thus	_	_	_	_
22-2	2907-2908	,	_	_	_	_
22-3	2909-2911	it	event	new	cata	22-3[0_157]
22-4	2912-2914	is	_	_	_	_
22-5	2915-2922	crucial	_	_	_	_
22-6	2923-2925	to	event[157]	new[157]	_	_
22-7	2926-2933	develop	event[157]	new[157]	_	_
22-8	2934-2935	a	event[157]|abstract[158]	new[157]|giv[158]	_	_
22-9	2936-2942	facile	event[157]|abstract[158]	new[157]|giv[158]	_	_
22-10	2943-2952	technique	event[157]|abstract[158]	new[157]|giv[158]	_	_
22-11	2953-2956	for	_	_	_	_
22-12	2957-2965	creating	_	_	_	_
22-13	2966-2978	microfluidic	person|object[160]	giv|giv[160]	coref|coref	23-14[170_160]|27-15
22-14	2979-2986	devices	object[160]	giv[160]	_	_
22-15	2987-2991	that	_	_	_	_
22-16	2992-2995	can	_	_	_	_
22-17	2996-3003	satisfy	_	_	_	_
22-18	3004-3007	the	abstract[161]	new[161]	_	_
22-19	3008-3020	requirements	abstract[161]	new[161]	_	_
22-20	3021-3023	of	abstract[161]	new[161]	_	_
22-21	3024-3028	cell	abstract[161]|place|abstract[163]	new[161]|giv|giv[163]	coref	22-24
22-22	3029-3039	separation	abstract[161]|abstract[163]	new[161]|giv[163]	_	_
22-23	3040-3043	and	abstract[161]	new[161]	_	_
22-24	3044-3048	cell	abstract[161]|place|abstract[165]	new[161]|giv|giv[165]	_	_
22-25	3049-3057	trapping	abstract[161]|abstract[165]	new[161]|giv[165]	_	_
22-26	3058-3059	.	_	_	_	_

#Text=In this paper , we present optofluidic maskless lithography for rapid fabrication of microfluidic devices .
23-1	3060-3062	In	_	_	_	_
23-2	3063-3067	this	abstract[166]	new[166]	_	_
23-3	3068-3073	paper	abstract[166]	new[166]	_	_
23-4	3074-3075	,	_	_	_	_
23-5	3076-3078	we	person	acc	_	_
23-6	3079-3086	present	_	_	_	_
23-7	3087-3098	optofluidic	object[168]	giv[168]	_	_
23-8	3099-3107	maskless	object[168]	giv[168]	_	_
23-9	3108-3119	lithography	object[168]	giv[168]	_	_
23-10	3120-3123	for	_	_	_	_
23-11	3124-3129	rapid	abstract[169]	giv[169]	coref	24-14[175_169]
23-12	3130-3141	fabrication	abstract[169]	giv[169]	_	_
23-13	3142-3144	of	abstract[169]	giv[169]	_	_
23-14	3145-3157	microfluidic	abstract[169]|object[170]	giv[169]|giv[170]	_	_
23-15	3158-3165	devices	abstract[169]|object[170]	giv[169]|giv[170]	_	_
23-16	3166-3167	.	_	_	_	_

#Text=Poly(ethylene glycol ) diacrylate ( PEGDMA ) was selected as the material for microstructures fabrication , and the cured microstructures were firmly adhered to the substrate .
24-1	3168-3181	Poly(ethylene	substance|object[172]	new|giv[172]	_	_
24-2	3182-3188	glycol	object[172]	giv[172]	_	_
24-3	3189-3190	)	_	_	_	_
24-4	3191-3201	diacrylate	_	_	_	_
24-5	3202-3203	(	_	_	_	_
24-6	3204-3210	PEGDMA	object	new	_	_
24-7	3211-3212	)	_	_	_	_
24-8	3213-3216	was	_	_	_	_
24-9	3217-3225	selected	_	_	_	_
24-10	3226-3228	as	_	_	_	_
24-11	3229-3232	the	_	_	_	_
24-12	3233-3241	material	_	_	_	_
24-13	3242-3245	for	_	_	_	_
24-14	3246-3261	microstructures	object|abstract[175]	giv|giv[175]	coref	24-18[176_0]
24-15	3262-3273	fabrication	abstract[175]	giv[175]	_	_
24-16	3274-3275	,	_	_	_	_
24-17	3276-3279	and	_	_	_	_
24-18	3280-3283	the	object[176]	giv[176]	_	_
24-19	3284-3289	cured	object[176]	giv[176]	_	_
24-20	3290-3305	microstructures	object[176]	giv[176]	_	_
24-21	3306-3310	were	_	_	_	_
24-22	3311-3317	firmly	_	_	_	_
24-23	3318-3325	adhered	_	_	_	_
24-24	3326-3328	to	_	_	_	_
24-25	3329-3332	the	object[177]	new[177]	_	_
24-26	3333-3342	substrate	object[177]	new[177]	_	_
24-27	3343-3344	.	_	_	_	_

#Text=The structures of microfluidic chips were on-line designed , and the exposure patterns were modulated by digital micromirror device ( DMD ) .
25-1	3345-3348	The	abstract[178]	new[178]	_	_
25-2	3349-3359	structures	abstract[178]	new[178]	_	_
25-3	3360-3362	of	abstract[178]	new[178]	_	_
25-4	3363-3375	microfluidic	abstract[178]|object[179]	new[178]|new[179]	_	_
25-5	3376-3381	chips	abstract[178]|object[179]	new[178]|new[179]	_	_
25-6	3382-3386	were	_	_	_	_
25-7	3387-3394	on-line	_	_	_	_
25-8	3395-3403	designed	_	_	_	_
25-9	3404-3405	,	_	_	_	_
25-10	3406-3409	and	_	_	_	_
25-11	3410-3413	the	abstract[181]	new[181]	_	_
25-12	3414-3422	exposure	abstract|abstract[181]	new|new[181]	_	_
25-13	3423-3431	patterns	abstract[181]	new[181]	_	_
25-14	3432-3436	were	_	_	_	_
25-15	3437-3446	modulated	_	_	_	_
25-16	3447-3449	by	_	_	_	_
25-17	3450-3457	digital	object[183]	giv[183]	_	_
25-18	3458-3469	micromirror	object|object[183]	new|giv[183]	_	_
25-19	3470-3476	device	object[183]	giv[183]	_	_
25-20	3477-3478	(	_	_	_	_
25-21	3479-3482	DMD	abstract	new	_	_
25-22	3483-3484	)	_	_	_	_
25-23	3485-3486	.	_	_	_	_

#Text=Compared with traditional methods , the proposed system is more flexible and cost-efficient .
26-1	3487-3495	Compared	_	_	_	_
26-2	3496-3500	with	_	_	_	_
26-3	3501-3512	traditional	abstract[185]	giv[185]	_	_
26-4	3513-3520	methods	abstract[185]	giv[185]	_	_
26-5	3521-3522	,	_	_	_	_
26-6	3523-3526	the	abstract[186]	new[186]	_	_
26-7	3527-3535	proposed	abstract[186]	new[186]	_	_
26-8	3536-3542	system	abstract[186]	new[186]	_	_
26-9	3543-3545	is	_	_	_	_
26-10	3546-3550	more	_	_	_	_
26-11	3551-3559	flexible	_	_	_	_
26-12	3560-3563	and	_	_	_	_
26-13	3564-3578	cost-efficient	_	_	_	_
26-14	3579-3580	.	_	_	_	_

#Text=Furthermore , microwell arrays with various shapes and sizes can be constructed on the microfluidic chip .
27-1	3581-3592	Furthermore	_	_	_	_
27-2	3593-3594	,	_	_	_	_
27-3	3595-3604	microwell	event|object[188]	giv|giv[188]	_	_
27-4	3605-3611	arrays	object[188]	giv[188]	_	_
27-5	3612-3616	with	object[188]	giv[188]	_	_
27-6	3617-3624	various	object[188]|abstract[189]	giv[188]|new[189]	_	_
27-7	3625-3631	shapes	object[188]|abstract[189]	giv[188]|new[189]	_	_
27-8	3632-3635	and	object[188]	giv[188]	_	_
27-9	3636-3641	sizes	object[188]|quantity	giv[188]|new	_	_
27-10	3642-3645	can	_	_	_	_
27-11	3646-3648	be	_	_	_	_
27-12	3649-3660	constructed	_	_	_	_
27-13	3661-3663	on	_	_	_	_
27-14	3664-3667	the	object[192]	new[192]	_	_
27-15	3668-3680	microfluidic	person|object[192]	giv|new[192]	_	_
27-16	3681-3685	chip	object[192]	new[192]	_	_
27-17	3686-3687	.	_	_	_	_
